An Australian case of New World cutaneous leishmaniasis

Pamela Konecny and Damien J Stark
Med J Aust 2007; 186 (6): 315-317.

Clinical record

Please login with your free MJA account to view this article in full

  • Pamela Konecny1,2
  • Damien J Stark3

  • 1 Department of Immunology and Infectious Diseases, St George Hospital, Sydney, NSW.
  • 2 University of New South Wales, Sydney, NSW.
  • 3 Department of Microbiology, St Vincent's Hospital, Sydney, NSW.


We wish to acknowledge the Department of Microbiology, South Eastern Area Laboratory Services, St George Hospital, for their support in isolating and maintaining the Leishmania parasite. We would also like to thank Associate Professor John Harkness of St Vincent’s Hospital Microbiology Department for his support in setting up the molecular testing for Leishmania.

Competing interests:

None identified.

  • 1. Schonian GA, Nasereddin N, Dinse C, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 2003; 47: 349-358.
  • 2. Rotureau B, Ravel C, Couppie P, et al. Use of PCR-restriction fragment length polymorphism analysis to identify the main new world Leishmania species and analyse their taxonomic properties and polymorphism by application of the assay to clinical samples. J Clin Microbiol 2006; 44: 459-467.
  • 3. Bryceson ADM. Leishmaniasis. In: Cook GC, editor. Manson’s tropical diseases. London: WB Saunders, 1996: 1213-1245.
  • 4. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
  • 5. Jones T, Johnson WJ, Barretto A, et al. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 1987; 156: 73-83.
  • 6. Berman J. Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 2003; 16: 397-401.
  • 7. Brown M, Noursadeghi M, Boyle J, Davidson RN. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Br J Dermatol 2005; 153: 203-205.
  • 8. Schwartz E, Hatz C, Blum J. New World cutaneous leishmaniasis in travellers. Lancet Infect Dis 2006; 6: 342-349.
  • 9. Ju O, Grove DI, Jaksic WJ, Dart GW. Visceral leishmaniasis: a trip to the Greek Islands is not always idyllic. Med J Aust 2004; 181: 446-447. <MJA full text>
  • 10. Maguire GP, Bastian I, Arianayagam S, et al. New World cutaneous leishmaniasis imported into Australia. Pathology 1998; 30: 73-76.
  • 11. Rose K, Curtis J, Baldwin T, et al. Cutaneous leishmaniasis in red kangaroos: isolation and characterisation of the causative organisms. Int J Parasitol 2004; 34: 655-664.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.